Du er her:
» Christian Lodberg Hvas
Christian Lodberg Hvas
PhD, Klinisk lektor, overlæge, ph.d.
Christian Lodberg Hvas
Klinisk lektor, overlæge, ph.d.
- Institut for Klinisk Medicin - Lever-, Mave- og Tarmsygdomme
Adressetype: Postaddresse.
Palle Juul-Jensens Boulevard 35
8200
Aarhus N
Danmark
E-mail: chrishva@rm.dk
Mobil: +4528351839
Telefon: +4578463892
Resumé
Læge 2000, speciallæge i intern medicin, gastroenterologi og hepatologi 2012.
Ph.d. 2007, klinisk lektor 2015.
Siden 2014 overlæge ved Medicinsk Hepato-Gastroenterologisk Afdeling V, Aarhus Universitetshospital.
Uddannelsesophold ved Institut für Klinische Molekularbiologie, Christian-Albrecht Universität, Kiel, 2005, og Intestinal Failure Unit, Salford Royal NHS Foundation Trust, Manchester, 2013.
Arbejdsområder inden for tarmsvigt og svær malabsorption samt kronisk inflammatoriske tarmsygdomme.
Forskning inden for tarmsvigt, cellulær immunologi, tarmbakterier, kronisk inflammatorisk tarmsygdom, cøliaki, klinisk ernæring.
Bred undervisningserfaring, præ- og postgraduat og populærvidenskabelig.
Ph.d. 2007, klinisk lektor 2015.
Siden 2014 overlæge ved Medicinsk Hepato-Gastroenterologisk Afdeling V, Aarhus Universitetshospital.
Uddannelsesophold ved Institut für Klinische Molekularbiologie, Christian-Albrecht Universität, Kiel, 2005, og Intestinal Failure Unit, Salford Royal NHS Foundation Trust, Manchester, 2013.
Arbejdsområder inden for tarmsvigt og svær malabsorption samt kronisk inflammatoriske tarmsygdomme.
Forskning inden for tarmsvigt, cellulær immunologi, tarmbakterier, kronisk inflammatorisk tarmsygdom, cøliaki, klinisk ernæring.
Bred undervisningserfaring, præ- og postgraduat og populærvidenskabelig.
Publikationer
Sodium depletion and secondary hyperaldosteronism in outpatients with an ileostomy: a cross-sectional study
Rud, C. L., Brantlov, S., Quist, J. R., Wilkens, T. L., Dahlerup, J. F., Lal, S., Jeppesen, P. B. & Hvas, C. L., 25 apr. 2023, (E-pub ahead of print) I: Scandinavian Journal of Gastroenterology. s. 1-9 9 s.Early Economic Assessment of Faecal Microbiota Transplantation for Patients with Urinary Tract Infections Caused by Multidrug-Resistant Organisms
Baek, O. D., Hjermitslev, C. K., Dyreborg, L., Baunwall, S. M. D., Høyer, K. L., Rågård, N., Hammeken, L. H., Povlsen, J. V., Ehlers, L. H. & Hvas, C. L., 16 apr. 2023, (E-pub ahead of print) I: Infectious diseases and therapy.Frailty level at discharge predicts mortality in older patients with Clostridioides difficile more accurately than age or disease severity
Rubak, T., Baunwall, S. M. D., Gregersen, M., Hansen, T. K., Rosenbæk, J. B., Erikstrup, L. T., Hvas, C. L. & Damsgaard, E. M. S., 13 apr. 2023, (E-pub ahead of print) I: European Geriatric Medicine. s. 1-11 11 s.Early Economic Assessment of Faecal Microbiota Transplantation for Patients with Urinary Tract Infections Caused by Multidrug-Resistant Organisms
Baek, O. D., Hjermitslev, C. K., Dyreborg, L., Dahl Baunwall, S. M., Høyer, K., Rågård, N., Hammeken, L. H., Povlsen, J., Ehlers, L. H. & Hvas, C. L., 27 mar. 2023, I: Early Economic Assessment of Faecal Microbiota Transplantation for Patients with Urinary Tract Infections Caused by Multidrug-Resistant Organisms.ESPEN guideline on Clinical Nutrition in inflammatory bowel disease
Bischoff, S. C., Bager, P., Escher, J., Forbes, A., Hébuterne, X., Hvas, C. L., Joly, F., Klek, S., Krznaric, Z., Ockenga, J., Schneider, S., Shamir, R., Stardelova, K., Bender, D. V., Wierdsma, N. & Weimann, A., mar. 2023, I: Clinical Nutrition. 42, 3, s. 352-379 28 s.Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection - Authors' reply
Baunwall, S. M. D., Andreasen, S. E., Hansen, M. M., Kelsen, J., Høyer, K. L., Rågård, N., Eriksen, L. L., Støy, S., Rubak, T., Damsgaard, E. M. S., Mikkelsen, S., Erikstrup, C., Dahlerup, J. F. & Hvas, C. L., feb. 2023, I: The Lancet. Gastroenterology & hepatology. 8, 2, s. 112-113 2 s.Nutritional risk screening in a Danish university hospital is insufficient and may underestimate nutritional risk: A cross-sectional study
Thomsen, T. K., Pedersen, J. L., Sloth, B., Damsgaard, E. M., Rud, C. L. & Hvas, C. L., feb. 2023, I: Journal of Human Nutrition and Dietetics. 36, 1, s. 108-115 8 s.Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease
van Lingen, E., Baunwall, S., Lieberknecht, S., Benech, N., Ianiro, G., Sokol, H., Gasbarrini, A., Cammarota, G., Eriksen, M., van der Meulen-de Jong, A., Terveer, E., Verspaget, H., Vehreschild, M., Hvas, C. & Keller, J., jan. 2023, I: Therapeutic Advances in Gastroenterology. 16Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis
Porcari, S., Baunwall, S. M. D., Occhionero, A. S., Ingrosso, M. R., Ford, A. C., Hvas, C. L., Gasbarrini, A., Cammarota, G. & Ianiro, G., 2023, (E-pub ahead of print) I: Journal of Autoimmunity.Risk of Helicobacter pylori transmission by faecal microbiota transplantation via oral capsules
Grosen, A. K., Mikkelsen, S., Baunwall, S. M. D., Dahlerup, J. F., Erikstrup, L. T., Hvas, C. L. & Erikstrup, C., 2023, (Accepteret/In press) I: Clinical Microbiology and Infection.Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Clostridioides difficile infection
Wei, S., Bahl, M. I., Baunwall, S. M. D., Dahlerup, J. F., Hvas, C. L. & Licht, T. R., 31 dec. 2022, I: Gut Microbes. 14, 1, 13 s., 2084306.Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial
Dahl Baunwall, S. M., Andreasen, S. E., Hansen, M. M., Kelsen, J., Høyer, K., Rågård, N., Eriksen, L. L., Støy, S., Rubak, T. M. M., Damsgaard, E. M. S., Mikkelsen, S., Erikstrup, C., Dahlerup, J. F. & Hvas, C. L., dec. 2022, I: The Lancet Gastroenterology and Hepatology. 7, 12, s. 1083-1091 9 s.Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report
Wei, S., Jespersen, M. L., Baunwall, S. M. D., Myers, P. N., Smith, E. M., Dahlerup, J. F., Rasmussen, S., Nielsen, H. B., Licht, T. R., Bahl, M. I. & Hvas, C. L., nov. 2022, I: Microbiome. 10, 193.IBD Håndbogen
Bager, P., Edelbo, R., Hvas, C. L., Johansen, K. B. & Julsgaard, M., nov. 2022, 5 udg. København: Ferring Lægemidler A/S. 106 s.Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel
Ianiro, G., Mullish, B. H., Iqbal, T. H., Terveer, E. M., Baunwall, S. M. D., Link, A., Sokol, H., Kupcinskas, J., Masucci, L., Sanguinetti, M., Vehreschild, M. J. G. T., Hvas, C. L., Keller, J. J., Gasbarrini, A., Kujiper, E. J. & Cammarota, G., nov. 2022, I: The Lancet Gastroenterology and Hepatology. 7, 11, s. 979-980 2 s.Standardised survival and excess Life Years Lost in patients with type 3 intestinal failure
Kopczynska, M., Hvas, C. L., Jepsen, P., Teubner, A., Abraham, A., Burden, S. T., Taylor, M., Carlson, G. & Lal, S., nov. 2022, I: Clinical Nutrition. 41, 11, s. 2446-2454 9 s.Impact of fibre and red/processed meat intake on treatment outcomes among patients with chronic inflammatory diseases initiating biological therapy: A prospective cohort study
Overgaard, S. H., Sørensen, S. B., Munk, H. L., Nexøe, A. B., Glerup, H., Henriksen, R. H., Guldmann, T., Pedersen, N., Saboori, S., Hvid, L., Dahlerup, J. F., Hvas, C. L., Jawhara, M., Andersen, K. W., Pedersen, A. K., Nielsen, O. H., Bergenheim, F., Brodersen, J. B., Heitmann, B. L., Halldorsson, T. I., Holmskov, U., Bygum, A., Christensen, R., Kjeldsen, J., Ellingsen, T. & Andersen, V., okt. 2022, I: Frontiers in nutrition. 9, 13 s., 985732.Patient-Reported Outcomes and Health-Related Quality of Life in People Living With Ileostomies: A Population-Based, Cross-Sectional Study
Rud, C. L., Baunwall, S. M. D., Bager, P., Dahlerup, J. F., Wilkens, T. L., Tøttrup, A., Lal, S. & Hvas, C. L., aug. 2022, I: Diseases of the Colon & Rectum. 65, 8, s. 1042-1051 10 s.Low-dose Methotrexate Therapy Does Not Affect Semen Parameters and Sperm DNA
Grosen, A., Bellaguarda, E., Nersting, J., Hvas, C. L., Liljeqvist-Soltic, I., Stein, A., Christensen, L. A., Ruderman, E. M., Brown, C. R., Schmiegelow, K., Zhang, J. X., Kelsen, J. & Hanauer, S. B., jul. 2022, I: Inflammatory Bowel Diseases. 28, 7, s. 1012-1018 7 s.Long-Term Outcomes in Patients with Intestinal Failure due to Short Bowel Syndrome and Intestinal Fistula
Kopczynska, M., Carlson, G., Teubner, A., Abraham, A., Taylor, M., Burden, S. T., Hvas, C. L., Jepsen, P. & Lal, S., apr. 2022, I: Nutrients. 14, 7, 13 s., 1449.Tarmbakterier: De største opdagelser i 2021, og hvad vi stadig stadig savner svar på
Hvas, C. L., feb. 2022Health-related quality of life in patients with recurrent Clostridioides difficile infections
Hammeken, L. H., Baunwall, S. M. D., Dahlerup, J. F., Hvas, C. L. & Ehlers, L. H., jan. 2022, I: Therapeutic Advances in Gastroenterology. 15, 8 s.Long-term maintenance treatment with 300 mg thiamine for fatigue in patients with inflammatory bowel disease: results from an open-label extension of the TARIF study
Bager, P., Hvas, C. L., Rud, C. L. & Dahlerup, J. F., jan. 2022, I: Scandinavian Journal of Gastroenterology. 57, 1, s. 37-43 7 s.Deep hyperammonemic hepatic encephalopathy precipitated by fecal microbiota transplantation for fulminant Clostridioides difficile infection
Eriksen, L. L., Baunwall, S. M. D., Eriksen, P. L., Bak-Fredslund, K. P., Nielsen, J. E., Dahlerup, J. F., Thomsen, K. L., Vilstrup, H. & Hvas, C. L., 2022, I: Gastroenterology Report. 10, 3 s., goab043.The record-based Multidimensional Prognostic Index predicts mortality in patients with Clostridioides difficile infection
Rubak, T. M. M., Dahl Baunwall, S. M., Gregersen, M., Kjærskov Hansen, T., Rosenbæk, J. B., Erikstrup, L. T., Hvas, C. L. & Damsgaard, E. M. S., 2022.Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review
Hammeken, L. H., Baunwall, S. M. D., Hvas, C. L. & Ehlers, L. H., dec. 2021, I: Health Economics Review. 11, 1, 8 s., 3.Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study
Julsgaard, M., Baumgart, D. C., Baunwall, S. M. D., Hansen, M. M., Grosen, A., Bibby, B. M., Uldbjerg, N., Kjeldsen, J., Sørensen, H. G., Larsen, L., Wildt, S., Weimers, P., Haderslev, K. V., Vind, I., Svenningsen, L., Brynskov, J., Lyhne, S., Vestergaard, T., Hvas, C. L., Kelsen, J. & NOVA Study Group, nov. 2021, I: Alimentary Pharmacology and Therapeutics. 54, 10, s. 1320-1329 10 s.Severity of Clostridium difficile infection among older patients: an observational pilot study
Rubak, T. M. M., Gregersen, M., Hvas, C. L., Dahl Baunwall, S. M., Kjærskov Hansen, T. & Damsgaard, E. M. S., okt. 2021.The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey
Baunwall, S. M. D., Terveer, E. M., Dahlerup, J. F., Erikstrup, C., Arkkila, P., Vehreschild, M. JGT., Ianiro, G., Gasbarrini, A., Sokol, H., Kump, P. K., Satokari, R., De Looze, D., Vermeire, S., Nakov, R., Brezina, J., Helms, M., Kjeldsen, J., Rode, A. A., Kousgaard, S. J., Alric, L., Trang-Poisson, C., Scanzi, J., Link, A., Stallmach, A., Kupcinskas, J., Johnsen, P. H., Garborg, K., Rodríguez, E. S., Serrander, L., Brummer, R. J., Galpérine, K. T., Goldenberg, S. D., Mullish, B. H., Williams, H. RT., Iqbal, T. H., Ponsioen, C., Kuijper, E. J., Cammarota, G., Keller, J. J. & Hvas, C. L., okt. 2021, I: The Lancet Regional Health - Europe. 9, 8 s., 100181.Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (FMT)
Baunwall, S. M. D., Dahlerup, J. F., Engberg, J. H., Erikstrup, C., Helms, M., Juel, M. A., Kjeldsen, J., Nielsen, H. L., Nilsson, A. C., Rode, A. A., Vinter-Jensen, L. & Hvas, C. L., sep. 2021, I: Scandinavian Journal of Gastroenterology. 56, 9, s. 1056-1077Systematic review with meta-analysis: effects of implementing a nutrition support team for in-hospital parenteral nutrition
Eriksen, M. K., Crooks, B., Dahl Baunwall, S. M., Rud, C. L., Lal, S. & Hvas, C. L., sep. 2021, I: Alimentary Pharmacology and Therapeutics. 54, 5, s. 560-570 11 s.Hypophosphatemia in a specialized intestinal failure unit: an observational cohort study
Eriksen, M. K., Baunwall, S. M. D., Lal, S., Dahlerup, J. F. & Hvas, C. L., aug. 2021, I: Journal of Parenteral and Enteral Nutrition. 45, 6, s. 1259-1267 9 s.Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy
Cold, F., Baunwall, S. M. D., Dahlerup, J. F., Petersen, A. M., Hvas, C. L. & Hansen, L. H., aug. 2021, I: Therapeutic Advances in Gastroenterology. 14, 19 s.Casein glycomacropeptide is well tolerated in healthy adults and changes neither high-sensitive C-reactive protein, gut microbiota nor faecal butyrate: a restricted randomised trial
Wernlund, P. G., Hvas, C. L., Dahlerup, J. F., Bahl, M. I., Licht, T. R., B Knudsen, K. E. & Agnholt, J. S., jun. 2021, I: The British Journal of Nutrition. 125, 12, s. 1374–1385 12 s.Determining Gut Microbial Dysbiosis: a Review of Applied Indexes for Assessment of Intestinal Microbiota Imbalances
Wei, S., Bahl, M. I., Baunwall, S. M. D., Hvas, C. L. & Licht, T. R., maj 2021, I: Applied and Environmental Microbiology. 87, 11, e00395-21.Reversibility of oxalate nephropathy in a kidney transplant recipient with prior gastric bypass surgery
Sørensen, C. G., Hvas, C. L., Thomsen, I. M. & Jespersen, B., maj 2021, I: Clinical Kidney Journal. 14, 5, s. 1478-1480 3 s.Letter: future studies of high-dose thiamine should consider whether its effects on fatigue are related to the inhibition of carbonic anhydrase isoenzymes. Authors' reply
Bager, P., Hvas, C., Rud, C. & Dahlerup, J., apr. 2021, I: Alimentary Pharmacology and Therapeutics. 53, 7, s. 853-854 2 s.SARS-CoV-2 vaccines and donor recruitment for FMT
Ianiro, G., Mullish, B. H., Hvas, C. L., Segal, J. P., Kuijper, E. J., Costello, S. P., Kelly, C. R., Allegretti, J. R., Fischer, M., Iqbal, T. H., Satokari, R., Kao, D., Prehn, J. V., Ng, S. C., Bibbò, S., Baunwall, S. M. D., Quraishi, M. N., Sokol, H., Zhang, F., Keller, J., Masucci, L., Quaranta, G., Kassam, Z., Sanguinetti, M., Tilg, H., Gasbarrini, A. & Cammarota, G., apr. 2021, I: The Lancet. Gastroenterology & hepatology. 6, 4, s. 264-266A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group
Keller, J. J., Ooijevaar, R. E., Hvas, C. L., Terveer, E. M., Lieberknecht, S. C., Högenauer, C., Arkkila, P., Sokol, H., Gridnyev, O., Mégraud, F., Kump, P. K., Nakov, R., Goldenberg, S. D., Satokari, R., Tkatch, S., Sanguinetti, M., Cammarota, G., Dorofeev, A., Gubska, O., Ianiro, G., Mattila, E., Arasaradnam, R. P., Sarin, S. K., Sood, A., Putignani, L., Alric, L., Baunwall, S. M., Kupcinskas, J., Link, A., Goorhuis, A. G., Verspaget, H. W., Ponsioen, C., Hold, G. L., Tilg, H., Kassam, Z., Kuijper, E. J., Gasbarrini, A., Mulder, C. J., Williams, H. R. & Vehreschild, M. J., mar. 2021, I: United European Gastroenterology Journal. 9, 2, s. 229-247 19 s.Editorial: a pipe dream fulfilled? A therapeutic option for fatigue in IBD. Authors' reply
Bager, P., Hvas, C. L., Rud, C. L. & Dahlerup, J. F., jan. 2021, I: Alimentary Pharmacology and Therapeutics. 53, 2, s. 344-345 2 s.Randomised clinical trial: high-dose oral thiamine versus placebo for chronic fatigue in patients with quiescent inflammatory bowel disease
Bager, P., Hvas, C. L., Rud, C. L. & Dahlerup, J. F., jan. 2021, I: Alimentary Pharmacology and Therapeutics. 53, 1, s. 79-86 8 s.The Citrullinated and MMP-degraded Vimentin Biomarker (VICM) Predicts Early Response to Anti-TNFα Treatment in Crohn's Disease
Mortensen, J. H., van Haaften, W. T., Karsdal, M. A., Bay-Jensen, A-C., Olinga, P., Grønbæk, H., Hvas, C. L., Manon-Jensen, T., Dijkstra, G. & Dige, A., jan. 2021, I: Journal of Clinical Gastroenterology. 55, 1, s. 59-66 8 s.Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis
Baunwall, S. M. D., Lee, M. M., Eriksen, M. K., Mullish, B. H., Marchesi, J. R., Dahlerup, J. F. & Hvas, C. L., dec. 2020, I: EClinicalMedicine. 29-30, 12 s., 100642.Nutritional status and predictors of weight loss in patients with systemic sclerosis
Hvas, C. L., Harrison, E., Eriksen, M. K., Herrick, A. L., McLaughlin, J. T. & Lal, S., dec. 2020, I: Clinical Nutrition ESPEN. 40, s. 164-170 7 s.Faecal microbiota transplantation as a home therapy to frail older people
Jørgensen, S. M. D., Rubak, T. M. M., Damsgaard, E. M., Dahlerup, J. F. & Hvas, C. L., okt. 2020, I: Age and Ageing. 49, 6, s. 1093-1096 4 s.Serological Biomarkers of Tissue Turnover Identify Responders to Anti-TNF Therapy in Crohn's Disease: A Pilot Study
van Haaften, W. T., Mortensen, J. H., Dige, A. K., Grønbæk, H., Hvas, C. L., Bay-Jensen, A. C., Karsdal, M. A., Olinga, P., Manon-Jensen, T. & Dijkstra, G., sep. 2020, I: Clinical and Translational Gastroenterology. 11, 9, e00217.Patient characteristics and clinical outcomes in a specialised intestinal failure unit: An observational cohort study
Eriksen, M. K., Jørgensen, S. M. D., Lemming, L. E., Lal, S., Dahlerup, J. F. & Hvas, C. L., aug. 2020, I: Clinical Nutrition ESPEN. 38, s. 253-262 10 s.Faecal microbiota transplantation: A life-saving therapy challenged by commercial claims for exclusivity
Hvas, C. L., Baunwall, S. M. D. & Erikstrup, C., jul. 2020, I: EClinicalMedicine. 24, 2 s., 100436.Faecal microbiota transplantation for eradication of co-infection with Clostridioides difficile and extensively drug-resistant KPC-producing Klebsiella pneumoniae
Bahl, M. I., Jørgensen, S. M. D., Skriver, A. H., Larsen, N. A., Wang, M., Licht, T. R., Dahlerup, J. F. & Hvas, C. L., maj 2020, I: Scandinavian Journal of Gastroenterology. 55, 5, s. 626-630 5 s.Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy-the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study
Zhao, M., Bendtsen, F., Petersen, A. M., Larsen, L., Dige, A., Hvas, C., Seidelin, J. B. & Burisch, J., 25 feb. 2020, I: BMJ Open. 10, 2, e035756.A Single Urine Sodium Measurement May Validly Estimate 24-hour Urine Sodium Excretion in Patients With an Ileostomy
Pedersen, A. K. N., Rud, C., Wilkens, T. L., Borre, M., Andersen, J. R., Dahlerup, J. F. & Hvas, C. L., feb. 2020, I: JPEN. Journal of parenteral and enteral nutrition. 44, 2, s. 246-255 10 s.Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes
Julsgaard, M., Hvas, C. L., Gearry, R. B., Gibson, P. R., Fallingborg, J., Sparrow, M. P., Bibby, B. M., Connell, W. R., Brown, S. J., Kamm, M. A., Lawrance, I. C., Vestergaard, T., Svenningsen, L., Baekdal, M., Kammerlander, H., Walsh, A., Boysen, T., Bampton, P., Radford-Smith, G., Kjeldsen, J., Andrews, J. M., Subramaniam, K., Moore, G. T., Jensen, N. M., Connor, S. J., Wildt, S., Wilson, B., Ellard, K., Christensen, L. A. & Bell, S. J., jan. 2020, I: Inflammatory Bowel Diseases. 26, 1, s. 93-102 10 s.Donated stool for faecal microbiota transplantation is not a drug, but guidance and regulation are needed
Keller, J. J., Vehreschild, M. J., Hvas, C. L., Jørgensen, S. M., Kupcinskas, J., Link, A., Mulder, C. J., Goldenberg, S. D., Arasaradnam, R., Sokol, H., Gasbarrini, A., Hoegenauer, C., Terveer, E. M., Kuijper, E. J. & Arkkila, P., 2020, I: United European Gastroenterology Journal. 8, 3, s. 353-354 2 s.Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug
Keller, J. J., Vehreschild, M. JGT., Hvas, C. L., Jørgensen, S. MD., Kupciskas, J., Link, A., Mulder, C. JJ., Goldenberg, S. D., Arasaradnam, R., Sokol, H., Gasbarrini, A., Hoegenauer, C., Terveer, E. M., Kuijper, E. J. & Arkkila, P., 14 nov. 2019, I: United European Gastroenterology Journal. 7, 10, s. 1408-1410 3 s.An iso-osmolar oral supplement increases natriuresis and does not increase stomal output in patients with an ileostomy: A randomised, double-blinded, active comparator, crossover intervention study
Rud, C., Pedersen, A. K. N., Wilkens, T. L., Borre, M., Andersen, J. R., Moeller, H. B., Dahlerup, J. F. & Hvas, C. L., okt. 2019, I: Clinical Nutrition. 38, 5, s. 2079-2086 8 s.Faecal Microbiota Transplantation Eradicated Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae from a Renal Transplant Recipient with Recurrent Urinary Tract Infections
Grosen, A. K., Povlsen, J., Lemming, L. E., Dahl Jørgensen, S. M., Dahlerup, J. F. & Hvas, C. L., aug. 2019, I: Case Reports in Nephrology and Dialysis. 9, 2, s. 102-107 6 s.Vedolizumab Does Not Impair Sperm DNA Integrity in Men With Inflammatory Bowel Disease
Grosen, A., Bungum, M., Hvas, C. L., Julsgaard, M., Cordelli, E. & Kelsen, J., 1 jun. 2019, I: Gastroenterology. 156, 8, s. 2342-2344 3 s.Semen Quality and Sperm DNA Integrity in Patients With Severe Active Inflammatory Bowel Disease and Effects of Tumour Necrosis Factor-alpha Inhibitors
Grosen, A., Bungum, M., Christensen, L. A., Cordelli, E., Larsen, O. H., Leter, G., Julsgaard, M., Vestergaard, T., Villani, P., Hvas, C. L. & Kelsen, J., maj 2019, I: Journal of Crohn's & Colitis. 13, 5, s. 564-571 8 s.Early changes in vitamin B12 uptake and biomarker status following Roux-en-Y gastric bypass and sleeve gastrectomy
Kornerup, L. S., Hvas, C. L., Abild, C. B., Richelsen, B. & Nexo, E., apr. 2019, I: Clinical Nutrition. 38, 2, s. 906-911 6 s.Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men with Inflammatory Bowel Disease
Grosen, A., Nersting, J., Bungum, M., Christensen, L. A., Schmiegelow, K., Spanò, M., Julsgaard, M., Cordelli, E., Leter, G., Larsen, P. B., Hvas, C. L. & Kelsen, J., 1 jan. 2019, I: Journal of Crohn's & Colitis. 13, 1, s. 3-11 9 s.Banking feces: a new frontier for public blood banks?
Jørgensen, S. M. D., Hvas, C. L., Dahlerup, J. F., Mikkelsen, S., Ehlers, L., Hammeken, L. H., Licht, T. R., Bahl, M. I. & Erikstrup, C., 2019, I: Transfusion. 59, 9, s. 2776-2782 7 s.Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection
Dehlholm-Lambertsen, E., Hall, B. K., Jørgensen, S. M. D., Jørgensen, C. W., Jensen, M. E., Larsen, S., Jensen, J. S., Ehlers, L., Dahlerup, J. F. & Hvas, C. L., 2019, I: Therapeutic Advances in Gastroenterology. 12, 14 s., 1756284819843002.Fecal Microbiota Transplantation is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection
Hvas, C. L., Jørgensen, S. M. D., Jørgensen, S. P., Storgaard, M., Lemming, L., Hansen, M. M., Erikstrup, C. & Dahlerup, J. F., 2019, I: Gastroenterology. 156, 5, s. 1324-1332.e3 13 s.Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature
Hvas, C. L., Ott, P., Paine, P., Lal, S., Jørgensen, S. P. & Dahlerup, J. F., 7 jun. 2018, I: World Journal of Gastroenterology. 24, 21, s. 2320-2326 7 s.Reduced 30-day gastrostomy placement mortality following the introduction of a multidisciplinary nutrition support team: a cohort study
Hvas, C. L., Farrer, K., Blackett, B., Lloyd, H., Paine, P. & Lal, S., jun. 2018, I: Journal of Human Nutrition and Dietetics. 31, 3, s. 413-421 9 s.Recruitment of feces donors among blood donors: Results from an observational cohort study
Dahl Jørgensen, S. M., Erikstrup, C., Dinh, K. M., Lemming, L. E., Dahlerup, J. F. & Hvas, C. L., 24 maj 2018, I: Gut Microbes. 9, 6, s. 540-550 11 s.Neurogen autonom dysfunktion hos voksne
Terkelsen, A. J., Hansen, J., Klostergaard, A., Otto, M., Mølgaard, H., Hvas, C. L., Krogh, K., Kirkeby, H. J., Andersen, H. & Jensen, T. S., 30 apr. 2018, I: Ugeskrift for Laeger. 180, 18, 6 s., V08170612.Neurogen autonom dysfunktion ved primær amyloidose
Terkelsen, A. J., Hansen, J., Klostergaard, A., Otto, M., Mølgaard, H., Hvas, C. L., Krogh, K., Kirkeby, H. J., Madsen, L. B., Andersen, H. & Jensen, T. S., 2 apr. 2018, I: Ugeskrift for Laeger. 180, 14, V12170927.Current, experimental, and future treatments in inflammatory bowel disease: a clinical review
Hvas, C. L., Bendix, M., Dige, A., Dahlerup, J. F. & Agnholt, J., 2018, I: Immunopharmacology and Immunotoxicology. 40, 6, s. 446-460 15 s.Faecal microbiota transplantation: establishment of a clinical application framework
Jørgensen, S. M. D., Hansen, M. M., Erikstrup, C., Dahlerup, J. F. & Hvas, C. L., nov. 2017, I: European Journal of Gastroenterology and Hepatology. 29, 11, s. 36-45 10 s.Immune responses and parasitological observations induced during probiotic treatment with medicinal Trichuris suis ova in a healthy volunteer
Williams, A. R., Dige, A., Rasmussen, T. K., Hvas, C. L., Dahlerup, J. F., Iversen, L., Stensvold, C. R., Agnholt, J. & Nejsum, P., aug. 2017, I: Immunology Letters. 188, s. 32-37 6 s.Ernæring og kosttilskud ved kronisk inflammatorisk tarmsygdom
Hvas, C. L., Borre, M. & Fassov, J., 31 jul. 2017, I: Ugeskrift for Laeger. 179, 22, s. 2-6 5 s.Nutrition and dietary supplement in chronic inflammatory bowel diesease
Hvas, C. L., Borre, M. & Fassov, J. L., 31 jul. 2017, I: Ugeskrift for Laeger. 179, 31Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease
Julsgaard, M., Hvas, C. L., Gearry, R. B., Vestergaard, T., Fallingborg, J., Svenningsen, L., Kjeldsen, J., Sparrow, M. P., Wildt, S., Kelsen, J. & Bell, S. J., jul. 2017, I: Inflammatory Bowel Diseases. 23, 7, s. 1240-1246 7 s.Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions
Bager, P., Hvas, C. L. & Dahlerup, J. F., maj 2017, I: British Journal of Clinical Pharmacology. 83, 5, s. 1118-1125 8 s.The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure
Grosen, A., Kelsen, J., Hvas, C. L., Bellaguarda, E. & Hanauer, S. B., 23 apr. 2017, I: Inflammatory Bowel Diseases. 23, 4, s. 561-569 9 s.Vitamin D increases programmed death receptor-1 expression in Crohn's disease
Bendix, M., Greisen, S., Dige, A., Hvas, C. L., Bak, N., Jørgensen, S. P., Dahlerup, J. F., Deleuran, B. & Agnholt, J., 11 apr. 2017, I: OncoTarget. 8, 15, s. 24177-24186 10 s.Mucosal and systemic immune modulation by Trichuris trichiura in a self-infected individual
Dige, A. K., Rasmussen, T. K., Nejsum, P., Hagemann-Madsen, R., Williams, A. R., Agnholt, J., Dahlerup, J. F. & Hvas, C. L., jan. 2017, I: Parasite Immunology. 8 s., e12394.Underernæring er en dræber på danske hospitaler
Nicolaisen, C., Ravn, A. W. & Hvas, C. L., 2017, I: Diætisten. 25, 148, s. 12-14 3 s.Reply: When Is It Safe to Administer Live Vaccines to Infants Exposed to Anti-Tumor Necrosis Factor Agents In Utero?
Julsgaard, M., Hvas, C. L., Christensen, L. A. & Bell, S. J., 1 nov. 2016, I: Gastroenterology. 151, 6, s. 1250-1251 2 s.Faecal microbiota transplantation for recurring Clostridium difficile infection in a patient with Crohn's disease and ileorectal anastomosis
Oppfeldt, A. M., Dahlerup, J. F., Christensen, L. A. & Hvas, C. L., 25 sep. 2016, I: BMJ Case Reports. 2016Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study
Hvas, C. L., Dige, A., Bendix Rasch, M., Wernlund, P. G., Christensen, L. A., Dahlerup, J. F. & Agnholt, J., jun. 2016, I: European Journal of Clinical Investigation. 46, 6, s. 555-63 9 s.Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
Julsgaard, M., Christensen, L. A., Gibson, P. R., Gearry, R. B., Fallingborg, J., Hvas, C. L., Bibby, B. M., Uldbjerg, N., Connell, W. R., Rosella, O., Grosen, A., Brown, S. J., Kjeldsen, J., Wildt, S., Svenningsen, L., Sparrow, M. P., Walsh, A., Connor, S. J., Radford-Smith, G., Lawrance, I. C., Andrews, J. M., Ellard, K. & Bell, S. J., 7 apr. 2016, I: Gastroenterology. s. 110-119 10 s., 151.Reversal of intestinal failure-associated liver disease (IFALD): emphasis on its multifactorial nature
Hvas, C., Kodjabashia, K., Nixon, E., Hayes, S., Farrer, K., Abraham, A. & Lal, S., apr. 2016, I: Frontline Gastroenterology. 7, 2, s. 114-117 4 s.Reduced numbers of mucosal DR(int) macrophages and increased numbers of CD103(+) dendritic cells during anti-TNF-α treatment in patients with Crohn's disease
Dige, A., Magnusson, M. K., Öhman, L., Hvas, C. L., Kelsen, J., Wick, M. J. & Agnholt, J., 19 jan. 2016, I: Scandinavian Journal of Gastroenterology. 51, 6, s. 692-9 8 s.Basisbog i medicin og kirurgi: Kapitel 6: Gastroenterologi
Hvas, C. L., 8 jan. 2016, 6 udg. København: Munksgaard. 42 s.Fæcestransplantation: afføring fra raske donorer som behandling af akutte og kroniske sygdomme
Hvas, C. L., 2016, I: Maanedsskrift for Almen Praksis. 94, 3, s. 203-211 9 s.Is fecal calprotectin the better tool to monitor disease activity in pregnant IBD patients?
Julsgaard (Mette Julsgaard Nielsen), M., Christensen, L. A., Hvas, C. L., Fallingborg, J., Svenningsen, L., Kjeldsen, J., Sparrow, M. P., Wildt, S. & Bell, S. J., 2016, s. Supplement 1 (A451-A452). 2 s.Symptoms and findings in adult-onset celiac disease in a historical Danish patient cohort
Schøsler, L., Christensen, L. A. & Hvas, C. L., 9 okt. 2015, I: Scandinavian Journal of Gastroenterology. s. 1-7 7 s.Introduction of a complete nutrition support team increases appropriate parenteral nutrition use and reduces its complications
Hvas, C. L., Farrer, K., Donaldson, E., Blackett, B., Lloyd, H., Forde, C., Paine, P. & Lal, S., okt. 2015, I: Clinical Nutrition ESPEN. 10, 5, s. e203Adalimumab and Infliximab Levels in Neonates (ERA Study)
Julsgaard (Mette Julsgaard Nielsen), M., Christensen, L. A., Gibson, P. R., Gearry, R., Fallingborg, J., Kjeldsen, J., Wildt, S., Svenningsen, L., Connell, W., Hvas, C. L., Sparrow, M. P., Walsh, A., Connor, S. J., Radford-Smith, G., Lawrence, I., Andrews, J. M., Ellard, K., Rosella, O., Grosen, A., Santamaria, J. & Bell, S. J., apr. 2015, I: Gastroenterology. 148, Supplement 1, s. S-108Celiac disease: diagnosis and treatment
Hvas, C. L., Jensen, M. D., Reimer, M. C., Riis, L. B., Rumessen, J. J., Skovbjerg, H., Teisner, A. & Wildt, S., apr. 2015, I: Danish Medical Journal. 62, 4, s. 1-13 13 s., c5051.Refeeding encephalopathy revisited: Reply to Tasci et al
Hvas, C. L., Becker, S. & Dam, G., 18 mar. 2015, I: European Journal of Clinical Nutrition. 69, s. 976 1 s.Adalimumab and Infliximab clearance in neonates (ERA study)
Julsgaard, M., Christensen, L. A., Gibson, P. R., Gearry, R., Fallingborg, J., Kjeldsen, J., Wildt, S., Svenningsen, L., Connell, W., Hvas, C. L., Sparrow, M. P., Walsh, A., Connor, S. J., Radford-Smith, G., Lawrence, I., Andrews, J. M., Ellard, K., Rosella, O., Grosen, A., Santamaria, J. & Bell, S., feb. 2015, I: Journal of Crohn's and Colitis.Refeeding encephalopathy in a patient with severe hypophosphataemia and hyperammonaemia
Becker, S., Dam, G. & Hvas, C. L., 2015, I: European Journal of Clinical Nutrition. 69, s. 279-81 3 s.Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease
Dige, A., Støy, S., Thomsen, K. L., Hvas, C. L., Agnholt, J., Dahlerup, J. F., Møller, H. J. & Grønbaek, H., nov. 2014, I: Scandinavian Journal of Immunology. 80, 6, s. 417-423Self-reported adherence to medical treatment, breastfeeding behaviour, and disease activity during the postpartum period in women with Crohn's disease
Julsgaard, M., Nørgaard, M., Hvas, C. L., Grosen, A., Hasseriis, S. & Christensen, L. A., 4 jun. 2014, I: Scandinavian Journal of Gastroenterology. s. 1-9 9 s.The lectin pathway of the complement system is downregulated in Crohn's disease patients who respond to anti-TNF-α therapy
Sandahl, T. D., Kelsen, J., Dige, A., Dahlerup, J. F., Agnholt, J., Hvas, C. L. & Thiel, S., 2 feb. 2014, I: Journal of Crohn's & Colitis. 8, 6, s. 521-8 9 s.Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn's disease patients
Bartels, L. E., Bendix, M., Hvas, C. L., Jørgensen, S. P., Agnholt, J., Agger, R. & Dahlerup, J. F., 1 feb. 2014, I: Inflammopharmacology. 22, 2, s. 95-103 9 s.Pregnancy outcome and counselling of anti-TNF-α treated IBD women.
Julsgaard, M., Christensen, L. A., Lawrence, I., Gearry, R., Connell, W., Grosen, A., Svenningsen, L., Andrews, J. M., Bampton, P., Walsh, A., Moore, G. T., Radford-Smith, G., Hvas, C. L., Kjeldsen, J., Connor, S. J., Sparrow, M. P., Fallingborg, J. & Bell, S. J., feb. 2014, I: Journal of Crohn's and Colitis. 8, P377Influence of medical treatment, smoking and disease activity on pregnancy outcomes in Crohn's disease
Julsgaard, M., Nørgaard, M., Hvas, C. L., Grosen, A., Hasseriis, S. & Christensen, L. A., 2014, I: Scandinavian Journal of Gastroenterology. 49, s. 302-308 7 s.Quality and safety impact on the provision of parenteral nutrition through introduction of a nutrition support team
Hvas, C. L., Farrer, K., Donaldson, E., Blackett, B., Lloyd, H., Forde, C., Garside, G., Paine, P. & Lal, S., 2014, I: European Journal of Clinical Nutrition. 68, s. 1294-9 5 s.Transplantation af tarmflora bliver standardbehandling: "Vi var trængt op i en krog"
Broberg Nielsen, H., Tvede, M., Hvas, C. L. & Leutscher, P., 2014, I: Danske Bioanalytikere. 4, s. 19-23 4 s.Active Crohn's disease is associated with low vitamin D levels
Jørgensen, S. P., Hvas, C. L., Agnholt, J., Christensen, L. A., Heickendorff, L. & Dahlerup, J. F., 1 nov. 2013, I: Journal of Crohn's & Colitis. 7, 10, s. e407–e413Biologic therapy in inflammatory bowel disease
Theede, K., Dahlerup, J. F., Fallingborg, J., Hvas, C. L., Kjeldsen, J., Munck, L. K. & Nordgaard-Lassen, I., jun. 2013, I: Danish Medical Journal. 60, 6, s. B465225-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn's disease
Bartels, L. E., Jørgensen, S. P., Bendix, M., Hvas, C. L., Agnholt, J., Agger, R. & Dahlerup, J. F., apr. 2013, I: Inflammopharmacology. 21, 2, s. 177-86 10 s.Is medical treatment a risk factor for adverse birth outcomes among women with Crohn’s disease?
Julsgaard, M., Nørgaard, M., Hvas, C. L., Grosen, A., Hasseriis, S. & Christensen, L. A., feb. 2013, I: Journal of Crohn's & Colitis. P207Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease
Dige, A., Støy, S., Rasmussen, T. K., Kelsen, J., Hvas, C. L., Sandahl, T. D., Dahlerup, J. F., Deleuran, B. & Agnholt, J., 2013, I: Journal of Crohn's & Colitis. 7, 3, s. 248-255A population-based study: Do women with ulcerative colitis breastfeed?
Julsgaard, M., Nørgaard, M., Hvas, C. L., Grosen, A., Hasseriis, S. & Christensen, L. A., 13 dec. 2012, I: Inflammatory Bowel Diseases. vol.18, no.12, s. 31Postpartum adherence to medical tratment among women with ulcerative colitis
Julsgaard, M., Nørgaard, M., Hvas, C. L., Buck, D. & Christensen, L. A., okt. 2012, I: Gut. 61, supplement 3, A28721 Days head-down bed rest induces weakening of cell-mediated immunity - Some spaceflight findings confirmed in a ground-based analog
Kelsen, J., Bartels, L. E., Dige, A., Hvas, C. L., Frings-Meuthen, P., Boehme, G., Thomsen, M. K., Fenger-Grøn, M. & Dahlerup, J. F., 2012, I: Cytokine. 59, 2, s. 403-9 7 s.Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells
Dige, A., Hvas, C. L., Deleuran, B., Kelsen, J., Bendix-Struve, M., Dahlerup, J. F. & Agnholt, J., 1 okt. 2011, I: Scandinavian Journal of Gastroenterology. 46, 10, s. 1206-14 9 s.Diagnosis and treatment of fistulising Crohn's disease
Hvas, C. L., Dahlerup, J. F., Jacobsen, B. A., Ljungmann, K., Qvist, N., Staun, M. & Tøttrup, A., 1 okt. 2011, I: Danish Medical Bulletin (Online). 58, 10, s. C4338Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis
Julsgaard, M., Nørgaard, M., Hvas, C. L., Buck, D. & Christensen, L. A., 1 jul. 2011, I: Inflammatory Bowel Diseases. 17, 7, s. 1573-80 8 s.Infliximab Induces Clonal Expansion of γδ-T Cells in Crohn’s Disease: A Predictor of Lymphoma Risk?
Kelsen, J., Schwindt, H., Dige, A. K., D'Amore, F. A., Pedersen, F. S., Agnholt, J., Christensen, L. A., Dahlerup, J. F. & Hvas, C. L., 31 mar. 2011, I: P L o S One. 6, 3, s. e17890 9 s.A populationbased study: Do women with Crohn’s disease breastfeed?
Nielsen, M. J., Nørgaard, M., Hvas, C. L., Buck, D. & Christensen, L. A., 2011, I: Journal of Crohn's & Colitis. vol.5, Issue 1, P055Cøliaki: en voksensygdom
Hvas, C. L., Borre, M. & Bonderup, O., 2011, I: Månedsskrift for almen praksis. 89, 6, s. 546-554 8 s.Adherence to medical treatment among women with ulcerative colitis
Julsgaard, M., Nørgaard, M., Hvas, C. L., Buck, D. & Christensen, L. A., 2010, I: Scandinavian Journal of Gastroenterology. vol.45, supplement 247, s. 59-60Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study
Jørgensen, S. P., Agnholt, J., Glerup, H., Lyhne, S., Villadsen, G. E., Hvas, C. L., Bartels, L. E., Kelsen, J., Christensen, L. A. & Dahlerup, J. F., 2010, I: Alimentary Pharmacology and Therapeutics. 32, 3, s. 377-83 6 s.Discrete changes in circulating regulatory T cells during infliximab treatment of Crohn's disease
Hvas, C. L., Kelsen, J., Agnholt, J., Dige, A., Christensen, L. A. & Dahlerup, J. F., 2010, I: Autoimmunity. 43, 4, s. 325-33 8 s.Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation
Bartels, L. E., Hvas, C. L., Agnholt, J., Dahlerup, J. F. & Agger, R., 2010, I: International Immunopharmacology. 10, 8, s. 922-8 7 s.Infliximab drives gamma-delta T cell expansion in Crohn's disease - a predictor of lymphoma risk?
Kelsen, J., Schwindt, H., Dige, A. K., D'Amore, F. A., Pedersen, F. S., Agnholt, J., Christensen, L. A., Dahlerup, J. F. & Hvas, C. L., 2010, I: Blood. 116, 21, s. 4131Medical treatment of ulcerative colitis patients prior to and during pregnancy
Nielsen, M. J., Nørgaard, M., Hvas, C. L., Buck, D. & Christensen, L. A., 2010, I: Scandinavian Journal of Gastroenterology. vol.45, supplement 247, s. 71-72Postpartum adherence to medical treatment among women with Crohn’s disease
Nielsen, M. J., Nørgaard, M., Hvas, C. L., Buck, D. & Christensen, L. A., 2010, I: Gut. vol.59, Supplement3, s. P0976Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways
Brosbøl-Ravnborg, A., Hvas, C. L., Agnholt, J., Dahlerup, J. F., Vind, I., Till, A., Rosenstiel, P. & Höllsberg, P., mar. 2009, I: Clinical and Experimental Immunology. 155, 3, s. 487-95 9 s.Ethylene-Diamine-Tetra-Acetate (EDTA) mimics the effect of regulatory T cells in suppression assays: A potential pitfall when using AutoMACS-separated cells
Dige, A., Hvas, C. L., Kelsen, J., Deleuran, B., Dahlerup, J. F. & Agnholt, J., 2009, I: Journal of Immunological Methods. s. 141-144Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways
Ravnborg, A. B., Hvas, C. L., Agnholt, J., Dahlerup, J. F., Vind, I., Till, A., Rosenstiel, P. & Höllsberg, P., 2009, I: Clinical and Experimental Immunology. 155, s. 487-95Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria
Hvas, C. L., Kelsen, J., Agnholt, J., Höllsberg, P., Tvede, M., Møller, J. K. & Dahlerup, J. F., maj 2007, I: Scandinavian Journal of Gastroenterology. Supplement. 42, 5, s. 592-601 10 s.Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease
Agnholt, J., Kelsen, J., Schack, L., Hvas, C. L., Dahlerup, J. F. & Sørensen, E. S., maj 2007, I: Scandinavian Journal of Immunology. 65, 5, s. 453-60 8 s.1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease
Bartels, L. E., Jørgensen, S. P., Agnholt, J., Kelsen, J., Hvas, C. L. & Dahlerup, J. F., 2007, I: International Immunopharmacology. 7, 13, s. 1755-64 9 s.Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria
Hvas, C. L., Kelsen, J., Agnholt, J., Höllsberg, P., Tvede, M., Møller, J. K. & Dahlerup, J. F., 2007, I: Scandinavian Journal of Gastroenterology. 42, s. 592-601D-vitamin insufficiens - en mulig aetiologisk faktor ved autoimmune sygdomme
Jørgensen, S. P., Bartels, L. E., Agnholt, J., Glerup, H., Nielsen, S. L., Hvas, C. L. & Dahlerup, J. F., 2007, I: Ugeskrift for Laeger. 169, 43, s. 3655-60 5 s.Modulation of cellular immune responses by bacterial products. Implications for Crohn's disease
Hvas, C. L., 2007, Aarhus Universitet.Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease
Agnholt, J., Kelsen, J., Schack, L., Hvas, C. L., Dahlerup, J. F. & Sørensen, E. S., 2007, I: Scand. J. Immunol.. 65, s. 453-60CD4 + CD25 + -regulatoriske T-celler og deres betydning for sygdomme hos mennesker
Kelsen, J., Hvas, C. L., Agnholt, J. & Dahlerup, J. F., 3 jan. 2006, I: Ugeskrift for Laeger. 168, 1, s. 32-7 6 s.CD4+CD25+-regulatoriske T-celler og deres betydning for sygdomme hos mennesker
Kelsen, J., Hvas, C. L., Agnholt, J. & Dahlerup, J. F., 2006, I: Ugeskrift for Laeger. 168, s. 32-7Når venner bliver fjender. Tarmens immunsystem på afveje
Hvas, C. L., 2006, I: Dagens Medicin.Crohn disease intestinal CD4+ T cells show interleukin-10 response to microbial antigens
Hvas, C. L., 2005.Cultivation of FoxP3+CD4+CD25+ regulatory T cells from colonic mucosa of patients with Crohn′s disease
Kelsen, J., Agnholt, J., Hoffmann, H. J., Romer, J. L., Hvas, C. L. & Dahlerup, J. F., 2005, I: Clin. Exp. Immunol.. 141, s. 549-57FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease
Kelsen, J., Agnholt, J., Hoffmann, H. J., Rømer, J. L., Hvas, C. L. & Dahlerup, J. F., 2005, I: Clinical and Experimental Immunology. 141, 3, s. 549-57 8 s.FoxP3+CD4+CD25+ T cells with regulatory properties can be cultured from colonic mucosa of patients with ChrFoxP3+CD4+CD25+T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
Kelsen, J., Agnholt, J., Hvas, C. L., Dahlerup, J. F. & Hofmann, H. J., 2005, I: Clin. Exp. Immunol..Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight
Hvas, C. L., Henriksen, T. B., Ostergaard, J. R. & Dam, M., jul. 2000, I: B J O G. 107, 7, s. 896-902 7 s.Birth weight in offspring of women with epilepsy
Hvas, C. L., Henriksen, T. B. & Østergaard, J. R., 2000, I: Epidemiologic Reviews. 22, 2, s. 275-82 8 s.Epilepsy during pregnancy and low birth weight: diploma thesis
Hvas, C. L., 1999, 49 s. The Faculty of Health Sciences, University of Aarhus.Min uddannelse, mit virke - hænger de sammen
Hvas, C. L., 1996, I: Ugeskrift for Læger. 158, 2, s. 192-194 2 s.Skæbner i den afrikanske bush
Hvas, C. L., 21 maj 1990, I: Kristeligt Dagblad.Bevillinger
Borregaard Clinical Ascending Investigator
Hvas, C. L.
Novo Nordisk Fonden: 9.994.530,00 kr.
01/01/2023 → 31/12/2027
ChiFT: Faecal microbiota transplantation to prevent complications, progression and mortality of cirrhosis
Vilstrup, H. V. A., Thomsen, K. L., Hvas, C. L., Støy, S., Eriksen, L. L., Baunwall, S. M. D., Patel, V. C., Licht, T. R. & Ehlers, L. H.
Novo Nordisk Fonden: 13.182.440,00 kr.
01/06/2021 → 31/05/2026
Fadigas: Fecal microbiota transplantation for chronic diarrhea in patients with diabetes mellitus: a randomized, double-blinded safety and efficacy study
Krogh, K., Høyer, K., Hvas, C. L., Drewes, A., Yderstraede, K. B. & Licht, T. R.
Novo Nordisk Fonden: 2.904.721,00 kr.
01/06/2020 → 31/05/2023
CEFTA: Centre for faecal microbiota transplantation
Hvas, C. L., Baunwall, S. M. D., Licht, T. R., Erikstrup, C., Dahlerup, J. F. & Ehlers, L. H.
Innovationsfonden, Grand Solutions: 17.122.860,00 kr.
01/10/2018 → 31/12/2024